Clinical Trial Update: The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis [Phase 1]

View source ↗

Summary

Phase 1 trial assessing intravenous immunoglobulin for critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness Myopathy
• Critical Illness Polyneuropathy
• Multiple Organ Dysfunction Syndrome
• Sepsis

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Polyneuropathies | Phase 1 | Status: TERMINATED